SW1088 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Brain cancer cell lines

Organism

Human

Donor History

Astrocytoma

Growth Properties

Adherent

Growth Conditions

Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/SW1088-Cells/305879

SKU: 305879 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The SW1088 cell line is a human glioma-derived line established from a tumor biopsy of the cerebral cortex. It is classified histologically as an astrocytoma and was originally reported in a study of tumorigenic human cell lines capable of forming tumors in nude mice. In that context, SW1088 was shown to form solid tumors when inoculated subcutaneously into immunodeficient hosts, although tumor development required longer latency periods compared to more aggressive glioblastoma cell lines. This suggests a relatively less proliferative or less aggressive phenotype in vivo.

SW1088 cells exhibit characteristics consistent with astrocytic origin and are commonly used in neuro-oncology research to model lower-grade gliomas. Their slower in vivo tumorigenicity compared to high-grade glioblastoma models such as U87MG or U251 reflects biological features relevant to astrocytoma pathology. Genomic and transcriptomic profiling of SW1088 has contributed to understanding molecular differences among glioma subtypes. However, these cells may not fully recapitulate the high-grade glioma phenotype due to their lower proliferation and reduced capacity for rapid tumor formation, making them a more suitable model for studying earlier-stage or less aggressive gliomas.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.